Top compounds associated with response to TSSC4


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.065 0.02
mRNA cabozantinib CTRPv2 pan-cancer AAC -0.083 0.02
mRNA Vandetanib FIMM pan-cancer AAC -0.38 0.02
mRNA dexamethasone CTRPv2 pan-cancer AAC 0.074 0.02
mRNA 5-FU CTRPv2 pan-cancer AAC -0.075 0.03
mRNA CI-1040 GDSC1000 pan-cancer AAC -0.072 0.03
mRNA JQ-1 CTRPv2 pan-cancer AAC -0.069 0.03
mRNA Crizotinib GDSC1000 pan-cancer AAC -0.12 0.03
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.03
mRNA GSK269962A GDSC1000 pan-cancer AAC 0.07 0.03
Download CSV